Results 201 to 210 of about 181,456 (327)

670. Combined Strategy of Minimal Myeloablation and Optimal BMT Regimen To Cure Murine β-Thalassemia [PDF]

, 2006
Hady Felfly, Marie Trudel
openalex   +1 more source

Analysis of clinical parameters of different types of α-thalassemia children in Hainan region, China. [PDF]

PeerJ
Gao G, Sun Z, Chen J, Kang J, Sun F, Li Q, Fu L, Gong Y, Ma L, Jie Q, Ma Y.   +10 more
europepmc   +1 more source

Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension

, 2014
Nonlawan Chueamuangphan, Jayanton Patumanond, Wattana Wongtheptien, Weerachai Nawarawong, Apichard Sukonthasarn, Suporn Chuncharunee, Chamaiporn Tawichasri   +6 more
openalex   +1 more source

David Weatherall wins the 2010 Lasker~Koshland Special Achievement Award in Medical Research for advances in thalassemia [PDF]

, 2010
Kathryn Claiborn
openalex   +1 more source

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 1, January 2026.
ABSTRACT Backgrounds Hydroxyurea (HU) remains underutilized in adults with sickle cell disease (SCD) despite proven benefits. Current HU guidelines primarily target sickle cell anemia (SCA), overlooking other genotypes. Objectives This study examined HU utilization patterns across genotypes among adults considered to have moderate to severe SCD ...
Siang‐Hao Cheng, Enrico M. Novelli, Hyeun Ah Kang, Terri V. Newman, Kangho Suh   +4 more
wiley   +1 more source

Protein Target Highlights in CASP16: Insights From the Structure Providers

Proteins: Structure, Function, and Bioinformatics, Volume 94, Issue 1, Page 25-50, January 2026.
ABSTRACT This article presents an in‐depth analysis of selected CASP16 targets, with a focus on their biological and functional significance. The authors highlight the most relevant features of the target proteins and discuss how well these were reproduced in the submitted predictions.
Leila T. Alexander, Océane M. Follonier, Andriy Kryshtafovych, Kim Abesamis, Sabrina Bibi‐Triki, Henry G. Box, Cécile Breyton, Françoise Bringel, Loic Carrique, Alessio d'Acapito, Gang Dong, Rebecca DuBois, Deborah Fass, Juliana Martinez Fiesco, Daniel R. Fox, Jonathan M. Grimes, Rhys Grinter, Matthew Jenkins, Roman Kamyshinsky, Jeremy R. Keown, Gerald Lackner, Michael Lammers, Shiheng Liu, Andrew L. Lovering, Tomas Malinauskas, Benoît Masquida, Gottfried J. Palm, Christian Siebold, Tiantian Su, Ping Zhang, Z. Hong Zhou, Krzysztof Fidelis, Maya Topf, John Moult, Torsten Schwede   +34 more
wiley   +1 more source

HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics

, 2016
Rhoda Elison Hirsch, Nathawut Sibmooh, Suthat Fucharoen, Joel M. Friedman   +3 more
openalex   +1 more source

Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease. [PDF]

Int J Gen Med
Lan L, Zheng Z, Wu H.
europepmc   +1 more source

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

Small Methods, Volume 10, Issue 2, 22 January 2026.
The review presents a comprehensive overview of each component of lipid nanoparticles（LNPs）and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu, Nei Li, Yudian Xiao, Rohan Palanki, Hannah Yamagata, Michael J. Mitchell, Xuexiang Han   +6 more
wiley   +1 more source

Identification of maternal ^Gγ(^Aγδβ)⁰ thalassemia through retrospective reanalysis of prenatal cfDNA sequencing data. [PDF]

Ann Med
Zhu X, Hu L, Pei Y, Ran J, Wen L, Zhong J, Zhu Y, Zeng K, Wei F, Liu W.   +9 more
europepmc   +1 more source